ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.96−0.03 (-3.03%)
Close on Nov 12, 2026Market cap $25.59MP/E –Yield –
ABVC BioPharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
ABVC BioPharma's total debt was $30.00K at Sep 30, 2026. For fiscal 2025 it was $755.51K, down 10.1% from the year before. The highest annual figure on record is $1.92M in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $755.51K | -10.1% |
| FY2024 | Dec 31, 2024 | $840.25K | -6.6% |
| FY2023 | Dec 31, 2023 | $899.25K | -52.5% |
| FY2022 | Dec 31, 2022 | $1.89M | +15.5% |
| FY2021 | Dec 31, 2021 | $1.64M | +0.7% |
| FY2020 | Dec 31, 2020 | $1.63M | -15.1% |
| FY2019 | Dec 31, 2019 | $1.92M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $30.00K | -96.3% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $59.46K | -93.2% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $88.74K | -88.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $755.51K | -10.1% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $809.10K | -9.7% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $871.95K | +2.9% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $801.41K | -6.9% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $840.25K | -6.6% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $896.25K | +5.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $847.00K | -4.0% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $860.75K | -4.6% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $899.25K | -52.5% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $852.50K | -54.3% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $882.75K | -43.9% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $902.00K | -44.0% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $1.89M | +15.5% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $1.87M | +14.0% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $1.57M | -2.6% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $1.61M | -1.2% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $1.64M | -3.5% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $1.64M | -2.8% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $1.62M | -15.8% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $1.63M | -13.6% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $1.70M | -27.3% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $1.69M | -17.8% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $1.92M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $1.89M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $2.34M | – |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | $2.05M | – |
See a number that looks wrong?